{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T04:11:46Z","timestamp":1793419906000,"version":"4.5.0"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T00:00:00Z","timestamp":1766966400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T00:00:00Z","timestamp":1766966400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Shaanxi Provincial People\u2019s Hospital Science and Technology Development Incubation Funding","award":["2023YJY-64"],"award-info":[{"award-number":["2023YJY-64"]}]},{"name":"Shaanxi Pharmaceutical Association Hospital pharmacy high-quality development research project","award":["2023-1-1-3"],"award-info":[{"award-number":["2023-1-1-3"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Microbiol Infect Dis"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1007\/s10096-025-05392-2","type":"journal-article","created":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T20:22:31Z","timestamp":1767039751000},"page":"905-912","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Efficacy and safety review of tosufloxacin in the treatment of bacterial infection in children"],"prefix":"10.1007","volume":"45","author":[{"given":"Suyun","family":"Yong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengjie","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8453-4648","authenticated-orcid":false,"given":"Mi","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,29]]},"reference":[{"issue":"02","key":"5392_CR1","first-page":"79","volume":"50","author":"National Health Commission of the People\u2019s Republic of China","year":"2023","unstructured":"National Health Commission of the People\u2019s Republic of China (2023) Guidelines for the diagnosis and treatment of Mycoplasma pneumoniae pneumonia in children(2023 edition). Int J Epidemiol Infect Diseas 50(02):79\u201385","journal-title":"Int J Epidemiol Infect Diseas"},{"issue":"8","key":"5392_CR2","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1111\/j.1348-0421.2001.tb01293.x","volume":"45","author":"N Okazaki","year":"2001","unstructured":"Okazaki N, Narita M, Yamada S, Izumikawa K, Umetsu M, Kenri T et al (2001) Characteristics of macrolide-resistant Mycoplasma pneumoniae strains isolated from patients and induced with erythromycin in vitro. Microbiol Immunol 45(8):617\u2013620","journal-title":"Microbiol Immunol"},{"key":"5392_CR3","doi-asserted-by":"publisher","first-page":"100480","DOI":"10.1016\/j.ijmmb.2023.100480","volume":"46","author":"S Kumar","year":"2023","unstructured":"Kumar S, Kumar S (2023) Mycoplasma pneumoniae: among the smallest bacterial pathogens with great clinical significance in children. Ind J Med Microbiol 46:100480","journal-title":"Ind J Med Microbiol"},{"key":"5392_CR4","doi-asserted-by":"publisher","first-page":"1306234","DOI":"10.3389\/fped.2023.1306234","volume":"11","author":"Z Song","year":"2023","unstructured":"Song Z, Jia G, Luo G, Han C, Zhang B, Wang X (2023) Global research trends of Mycoplasma pneumoniae pneumonia in children: a bibliometric analysis. Front Pediatr 11:1306234","journal-title":"Front Pediatr"},{"issue":"10","key":"5392_CR5","doi-asserted-by":"publisher","first-page":"e369","DOI":"10.1097\/INF.0000000000004041","volume":"42","author":"N Ishiwada","year":"2023","unstructured":"Ishiwada N, Shinjoh M, Kusama Y, Arakawa H, Ohishi T, Saitoh A et al (2023) Guidelines for the management of respiratory infectious diseases in children in Japan 2022. Pediatr Infect Disease J 42(10):e369\u2013e76","journal-title":"Pediatr Infect Disease J"},{"key":"5392_CR6","doi-asserted-by":"crossref","unstructured":"Suyun Yong M, Yang M, Zhou (2024) The efficacy and safety of tosufloxacin in the treatment of bacterial infections in children: systematic review. In: P1. Pediatric Bacterial studies (natural history and therapuetic): IDWEEK; P-1163. Available at: https:\/\/idweek2024.eventscribe.net\/searchbyposterbucket.asp?f=PosterSessionName&pfp=BrowsebyPosterSession","DOI":"10.1093\/ofid\/ofae631.1349"},{"issue":"10","key":"5392_CR7","doi-asserted-by":"publisher","first-page":"1719","DOI":"10.1039\/C9MD00120D","volume":"10","author":"TDM Pham","year":"2019","unstructured":"Pham TDM, Ziora ZM, Blaskovich MAT (2019) Quinolone antibiotics. MedChemComm 10(10):1719\u20131739","journal-title":"MedChemComm"},{"key":"5392_CR8","unstructured":"Tang M, Yang Z, Cai H (2010) Activity of 6 fluoroquinolones against Enterococcus faecalis in vitro [Chinese]. Int J Lab Med (12):1400\u20131401"},{"key":"5392_CR9","unstructured":"Kuang X, Zhou L, Wang Y et al (2005) Study on the in vitro and in vivo antibacterial activities of Sparfloxacin and Tosufloxacin [Chinese]. Chin J Antibiot (05):289\u2013294"},{"key":"5392_CR10","unstructured":"Cao Y, Zhang Y, Zhang J et al (1999) In vitro and in vivo activity of Tosufloxacin [Chinese]. Chin J Antibiot (02):138\u2013141"},{"issue":"1","key":"5392_CR11","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1007\/s00284-021-02729-w","volume":"79","author":"P She","year":"2021","unstructured":"She P, Li S, Liu Y, Xu L, Zhou L, Zeng X et al (2021) Repurposing Sitafloxacin, Prulifloxacin, Tosufloxacin, and Sisomicin as antimicrobials against biofilm and persister cells of Pseudomonas aeruginosa. Curr Microbiol 79(1):12","journal-title":"Curr Microbiol"},{"issue":"2","key":"5392_CR12","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1089\/jop.2020.0091","volume":"37","author":"H Eguchi","year":"2021","unstructured":"Eguchi H, Nishida K, Hotta F, Shimomura Y, Kusaka S (2021) In vitro antimicrobial activity of quinolones against major bacterial isolates from the ocular surface bacterial flora of tertiary hospital patients in Japan. J Ocular Pharmacol Therapeutics: Official J Association Ocular Pharmacol Ther 37(2):84\u201389","journal-title":"J Ocular Pharmacol Therapeutics: Official J Association Ocular Pharmacol Ther"},{"key":"5392_CR13","doi-asserted-by":"crossref","unstructured":"Oishi T, Yoshioka D, Nakano T, Ouchi K (2022) Recent trend of antimicrobial susceptibility among mycoplasma pneumoniae isolated from Japanese children. Microorganisms 10(12):2428","DOI":"10.3390\/microorganisms10122428"},{"issue":"6","key":"5392_CR14","doi-asserted-by":"publisher","first-page":"167","DOI":"10.3345\/kjp.2017.60.6.167","volume":"60","author":"HJ Yang","year":"2017","unstructured":"Yang HJ, Song DJ, Shim JY (2017) Mechanism of resistance acquisition and treatment of macrolide-resistant Mycoplasma pneumoniae pneumonia in children. Korean J Pediatr 60(6):167\u2013174","journal-title":"Korean J Pediatr"},{"key":"5392_CR15","doi-asserted-by":"crossref","unstructured":"Hiraoka M, Sugita G, Gunduz M, Gunduz E, Tamagawa S, Kono M et al (2019) Tosufloxacin for eradicating Biofilm-Forming nontypeable haemophilus influenzae isolated from intractable acute otitis media. Jundishapur J Microbiol 12(3):e69583","DOI":"10.5812\/jjm.69583"},{"key":"5392_CR16","unstructured":"Tosufloxacin Tosilate Hydrate (2020) Package insert. FujiFilm Toyama Chemical Co., Ltd."},{"issue":"SUPPL 2","key":"5392_CR17","first-page":"69","volume":"58","author":"K Sunakawa","year":"2010","unstructured":"Sunakawa K, Iwai N, Iwata S, Ouchi K, Sakata H, Suzuki K et al (2010) Population pharmacokinetics and pharmacodynamics of Tosufloxacin granules in pediatric infectious diseases. Japanese J Chemother 58(SUPPL 2):69\u201377","journal-title":"Japanese J Chemother"},{"key":"5392_CR18","first-page":"32","volume":"58","author":"S Iwata","year":"2010","unstructured":"Iwata S, NI, KO, HS KS (2010) An uncontrolled, open label study of 10% Tosufloxacin granules in pediatric pneumonia. Japanese J Chemother 58:32\u201349 ((SUPPL. 2))","journal-title":"Japanese J Chemother"},{"issue":"SUPPL 2","key":"5392_CR19","first-page":"78","volume":"58","author":"S Hori","year":"2010","unstructured":"Hori S, Irimajiri S, Koido N, Sunakawa K (2010) Safety profile of pediatric Tosufloxacin. Japanese J Chemother 58(SUPPL 2):78\u201388","journal-title":"Japanese J Chemother"},{"issue":"2","key":"5392_CR20","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.ijantimicag.2017.02.027","volume":"50","author":"M Morozumi","year":"2017","unstructured":"Morozumi M, Okada T, Tajima T, Ubukata K, Iwata S (2017) Killing kinetics of minocycline, Doxycycline and Tosufloxacin against macrolide-resistant Mycoplasma pneumoniae. Int J Antimicrob Agents 50(2):255\u2013257","journal-title":"Int J Antimicrob Agents"},{"issue":"5","key":"5392_CR21","doi-asserted-by":"publisher","first-page":"2252","DOI":"10.1128\/AAC.00048-13","volume":"57","author":"Y Kawai","year":"2013","unstructured":"Kawai Y, Miyashita N, Kubo M, Akaike H, Kato A, Nishizawa Y et al (2013) Therapeutic efficacy of macrolides, minocycline, and Tosufloxacin against macrolide-resistant Mycoplasma pneumoniae pneumonia in pediatric patients. Antimicrob Agents Chemother 57(5):2252\u20132258","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"5392_CR22","doi-asserted-by":"publisher","first-page":"199","DOI":"10.3345\/kjp.2018.07367","volume":"62","author":"H-J Yang","year":"2019","unstructured":"Yang H-J (2019) Benefits and risks of therapeutic alternatives for macrolide resistant Mycoplasma pneumoniae pneumonia in children. Korean J Pediatr 62(6):199\u2013205","journal-title":"Korean J Pediatr"},{"issue":"12","key":"5392_CR23","doi-asserted-by":"publisher","first-page":"1642","DOI":"10.1093\/cid\/cis784","volume":"55","author":"T Okada","year":"2012","unstructured":"Okada T, Morozumi M, Tajima T, Hasegawa M, Sakata H, Ohnari S et al (2012) Rapid effectiveness of Minocycline or Doxycycline against macrolide-resistant Mycoplasma pneumoniae infection in a 2011 outbreak among Japanese children. Clin Infect Diseases: Official Publication Infect Dis Soc Am 55(12):1642\u20131649","journal-title":"Clin Infect Diseases: Official Publication Infect Dis Soc Am"},{"key":"5392_CR24","doi-asserted-by":"crossref","unstructured":"Gotoh K, Nishimura N, Kito S, Haruta K, Kozawa K, Hibino H et al (2016) A randomized comparison of minocycline and tosufloxacin for the treatment of clinically macrolide-resistant mycoplasma pneumoniae pneumonia in \u2265\u20098-year-old Japanese children. Open Forum Infect Dis 3(suppl_1)","DOI":"10.1093\/ofid\/ofw172.924"},{"issue":"3","key":"5392_CR25","doi-asserted-by":"publisher","first-page":"e0173635","DOI":"10.1371\/journal.pone.0173635","volume":"12","author":"N Ishiguro","year":"2017","unstructured":"Ishiguro N, Koseki N, Kaiho M, Ariga T, Kikuta H, Togashi T et al (2017) Therapeutic efficacy of azithromycin, clarithromycin, Minocycline and Tosufloxacin against macrolide-resistant and macrolide-sensitive Mycoplasma pneumoniae pneumonia in pediatric patients. PLoS ONE 12(3):e0173635","journal-title":"PLoS ONE"},{"issue":"4","key":"5392_CR26","first-page":"585","volume":"65","author":"K Ouchi","year":"2017","unstructured":"Ouchi K, Takayama S, Fujioka Y, Sunakawa K, Iwata S (2017) A phase III, randomized, open-label study on 15% Tosufloxacin granules in pediatric Mycoplasma pneumoniae pneumonia. Japanese J Chemother 65(4):585\u2013596","journal-title":"Japanese J Chemother"},{"issue":"3","key":"5392_CR27","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/ja.2011.119","volume":"65","author":"H Sakata","year":"2012","unstructured":"Sakata H (2012) Clinical efficacy of Tosufloxacin in children with pneumonia due to Mycoplasma pneumoniae. Jpn J Antibiot 65(3):173\u2013179","journal-title":"Jpn J Antibiot"},{"issue":"2","key":"5392_CR28","first-page":"204","volume":"62","author":"S Iwata","year":"2014","unstructured":"Iwata S, Suzuki K, Takayama S, Sunakawa K (2014) Evaluation of safety and efficacy of Tosufloxacin granules for children in bacterial pneumonia and otitis media. Japanese J Chemother 62(2):204\u2013216","journal-title":"Japanese J Chemother"},{"key":"5392_CR29","doi-asserted-by":"crossref","unstructured":"Ahn JG, Cho H-K, Li D, Choi M, Lee J, Eun B-W et al (2021) Efficacy of tetracyclines and fluoroquinolones for the treatment of macrolide-refractory mycoplasma pneumoniae pneumonia in children: a systematic review and meta-analysis. BMC Infect Dis 21(1):1003","DOI":"10.1186\/s12879-021-06508-7"},{"issue":"4","key":"5392_CR30","first-page":"366","volume":"70","author":"S Iwata","year":"2022","unstructured":"Iwata S, YF, YJ SS (2022) Assessment of the incidence of joint-related adverse effects in patients under the age of 18 years treated with Tosufloxacin based on the Japanese health insurance claims database. Japanese J Chemother 70(4):366\u2013372","journal-title":"Japanese J Chemother"},{"issue":"6","key":"5392_CR31","doi-asserted-by":"publisher","first-page":"3399","DOI":"10.21037\/jtd-20-2256","volume":"13","author":"Y Kim","year":"2021","unstructured":"Kim Y, Park GW, Kim S, Moon HJ, Won S, Chung W et al (2021) Fluoroquinolone and no risk of Achilles-tendinopathy in childhood pneumonia under eight years of age-a nationwide retrospective cohort. J Thorac Disease 13(6):3399\u20133408","journal-title":"J Thorac Disease"},{"issue":"5","key":"5392_CR32","first-page":"613","volume":"62","author":"H Sakata","year":"2014","unstructured":"Sakata H, Iwata S, Ouchi K, Sato Y, Tsumura N, Sunakawa K (2014) Efficacy and safety of Tosufloxacin tosilate hydrate for the treatment of community-acquired pneumonia in children. Japanese J Chemother 62(5):613\u2013621","journal-title":"Japanese J Chemother"},{"issue":"7","key":"5392_CR33","first-page":"659","volume":"105","author":"N Yamanaka","year":"2013","unstructured":"Yamanaka N, Sugita R, Uno Y, Matsubara S, Hayashi Y, Sawada S (2013) Clinical characteristics of acute otitis media in children under the age of 2 years and the efficacy of Tosufloxacin. Pract Otorhinolaryngol 105(7):659\u2013667","journal-title":"Pract Otorhinolaryngol"},{"issue":"4","key":"5392_CR34","first-page":"381","volume":"105","author":"N Yamanaka","year":"2012","unstructured":"Yamanaka N, Sugita R, Uno Y, Matsubara S, Hayashi Y, Sawada S (2012) Clinical efficacy of Tosufloxacin tosilate hydrate for the treatment of acute otitis media in children. Pract Otorhinolaryngol 105(4):381\u2013392","journal-title":"Pract Otorhinolaryngol"},{"key":"5392_CR35","first-page":"50","volume":"10","author":"K Suzuki","year":"2010","unstructured":"Suzuki K, YI, FK, HT KS (2010) An uncontrolled, open label study of Tosufloxacin granules 10% in pediatric acute otitis media (AOM). Japanese J Chemother 10:50\u201368","journal-title":"Japanese J Chemother"},{"issue":"1","key":"5392_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s101560200000","volume":"8","author":"Y Niki","year":"2002","unstructured":"Niki Y (2002) Pharmacokinetics and safety assessment of Tosufloxacin tosilate. J Infect Chemotherapy: Official J Japan Soc Chemother 8(1):1\u201318","journal-title":"J Infect Chemotherapy: Official J Japan Soc Chemother"},{"issue":"9","key":"5392_CR37","doi-asserted-by":"publisher","first-page":"2353","DOI":"10.1093\/jac\/dkac170","volume":"77","author":"G Wang","year":"2022","unstructured":"Wang G, Wu P, Tang R, Zhang W (2022) Global prevalence of resistance to macrolides in Mycoplasma pneumoniae: a systematic review and meta-analysis. J Antimicrob Chemother 77(9):2353\u20132363","journal-title":"J Antimicrob Chemother"},{"issue":"7","key":"5392_CR38","doi-asserted-by":"publisher","first-page":"1782","DOI":"10.3390\/jcm11071782","volume":"11","author":"T Oishi","year":"2022","unstructured":"Oishi T, Ouchi K (2022) Recent trends in the Epidemiology, Diagnosis, and treatment of Macrolide-Resistant Mycoplasma pneumoniae. J Clin Med 11(7):1782","journal-title":"J Clin Med"},{"key":"5392_CR39","doi-asserted-by":"crossref","unstructured":"Spoial\u0103 EL, St\u00e2rcea IM, Ioniuc IK, Cozma RS, Rusu DC, Bozomitu L et al (2023) Watchful waiting in pediatric acute otitis media: a real practice approach or an intangible desideratum? Medicina (Kaunas, Lithuania) 59(3)","DOI":"10.3390\/medicina59030520"},{"key":"5392_CR40","doi-asserted-by":"crossref","unstructured":"Jamal A, Alsabea A, Tarakmeh M, Safar A, Etiology (2022) Diagnosis, complications, and management of acute otitis media in children. Cureus","DOI":"10.7759\/cureus.28019"},{"key":"5392_CR41","doi-asserted-by":"crossref","unstructured":"Kaur R, Morris M, Pichichero ME (2017) Epidemiology of acute otitis media in the postpneumococcal conjugate vaccine era. Pediatrics 140(3):e20170181","DOI":"10.1542\/peds.2017-0181"},{"issue":"10","key":"5392_CR42","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1542\/pir.19.10.327","volume":"19","author":"N Cimolai","year":"1998","unstructured":"Cimolai N (1998) Mycoplasma pneumoniae respiratory infection. Pediatr Rev 19(10):327\u2013332","journal-title":"Pediatr Rev"},{"issue":"1","key":"5392_CR43","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.jaip.2018.07.033","volume":"7","author":"ZH Liu","year":"2019","unstructured":"Liu ZH, Shen H (2019) Mycoplasma-Induced toxic epidermal necrolysis with severe mucositis. J Allergy Clin Immunol Pract 7(1):286\u2013287","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"Suppl 2","key":"5392_CR44","doi-asserted-by":"publisher","first-page":"S144","DOI":"10.1086\/428055","volume":"41","author":"RC Owens Jr","year":"2005","unstructured":"Owens RC Jr, Ambrose PG (2005) Antimicrobial safety: focus on fluoroquinolones. Clin Infect Dis 41(Suppl 2):S144\u2013S157","journal-title":"Clin Infect Dis"},{"issue":"1","key":"5392_CR45","doi-asserted-by":"publisher","first-page":"e15368","DOI":"10.1111\/ped.15368","volume":"64","author":"Y Atsumi","year":"2022","unstructured":"Atsumi Y, Yamanaka H, Shimozawa K, Yamanaka J, Uryu H, Mizukami A et al (2022) Drug-induced crystalluria attributable to Tosufloxacin in children. Pediatr Int 64(1):e15368","journal-title":"Pediatr Int"},{"issue":"5","key":"5392_CR46","first-page":"643","volume":"93","author":"T Tajima","year":"2019","unstructured":"Tajima T, Miyashita H, Mieno K, Sato Y, Shibuya Y, Koyama S et al (2019) Acute kidney injury after administration of Tosufloxacin tosilate in children with Mycoplasma pneumoniae pneumonia. J Japanese Association Infect Dis 93(5):643\u2013648","journal-title":"J Japanese Association Infect Dis"},{"issue":"4","key":"5392_CR47","first-page":"151","volume":"5","author":"N Takahashi","year":"2023","unstructured":"Takahashi N, Sugamori T, Hamaguchi S, Kijima T, Yamagata S, Makiishi T (2023) Tosufloxacin-induced severe hypoglycemia in a non-diabetic patient. J Hosp Gen Med 5(4):151\u2013154","journal-title":"J Hosp Gen Med"},{"issue":"4","key":"5392_CR48","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/j.anl.2020.05.019","volume":"47","author":"T Hayashi","year":"2020","unstructured":"Hayashi T, Kitamura K, Hashimoto S et al (2020) Clinical practice guidelines for the diagnosis and management of acute otitis media in children-2018 update. Auris Nasus Larynx 47(4):493\u2013526","journal-title":"Auris Nasus Larynx"},{"issue":"1","key":"5392_CR49","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s13052-025-01894-z","volume":"51","author":"G Castelli Gattinara","year":"2025","unstructured":"Castelli Gattinara G, Bergamini M, Simeone G et al (2025) Antibiotic treatment of acute and recurrent otitis media in children: an Italian intersociety consensus. Ital J Pediatr 51(1):50","journal-title":"Ital J Pediatr"},{"issue":"10","key":"5392_CR50","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.3201\/eid2310.170106","volume":"23","author":"T Tanaka","year":"2017","unstructured":"Tanaka T, Oishi T, Miyata I, Wakabayashi S, Kono M, Ono S et al (2017) Macrolide-Resistant Mycoplasma pneumoniae Infection, Japan, 2008\u20132015. Emerg Infect Dis 23(10):1703\u20131706","journal-title":"Emerg Infect Dis"},{"key":"5392_CR51","doi-asserted-by":"crossref","unstructured":"Sasaki K, Yamada K, Matama C, Koike D, Hirade T, Mashino J et al (2024) A Japanese boy with spotted fever and overlapping symptoms of kawasaki disease: a case report. Cureus","DOI":"10.7759\/cureus.51915"},{"issue":"4","key":"5392_CR52","doi-asserted-by":"publisher","first-page":"377","DOI":"10.7883\/yoken.JJID.2020.621","volume":"74","author":"Y Yamaguchi","year":"2021","unstructured":"Yamaguchi Y, Kitano T, Onishi T, Takeyama M, Suzuki Y, Nogami K (2021) A case of pediatric subcutaneous abscess caused by Mycobacterium mageritense infection. Jpn J Infect Dis 74(4):377\u2013380","journal-title":"Jpn J Infect Dis"},{"issue":"5","key":"5392_CR53","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1007\/s40272-022-00513-2","volume":"24","author":"S Li","year":"2022","unstructured":"Li S, Chen Z, Huang L, Liu Z, Shi Y, Zhang M et al (2022) Safety of quinolones in children: A systematic review and Meta-Analysis. Paediatr Drugs 24(5):447\u2013464","journal-title":"Paediatr Drugs"}],"container-title":["European Journal of Clinical Microbiology & Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-025-05392-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10096-025-05392-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-025-05392-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T14:33:33Z","timestamp":1776350013000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10096-025-05392-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,29]]},"references-count":53,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["5392"],"URL":"https:\/\/doi.org\/10.1007\/s10096-025-05392-2","relation":{},"ISSN":["0934-9723","1435-4373"],"issn-type":[{"value":"0934-9723","type":"print"},{"value":"1435-4373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,29]]},"assertion":[{"value":"2 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not required.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not involved.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Sequence information"}}]}}